![Carol Odle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Carol Odle worked at La Jolla Pharmaceutical Co. from 2014 to 2020, serving as Director-Clinical Projects & Manager in 2020.
Ms. Odle worked at Revelation Biosciences, Inc. as Vice President-Clinical Operations from 2020 to 2022 and again from 2023 to 2026.
Eerdere bekende functies van Carol Odle
| Bedrijven | Functie | Einde |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Operationeel Directeur | 01-02-2026 |
| REVELATION BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2022 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01-08-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Revelation Biosciences, Inc.
 Revelation Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics and diagnostics for viral infections | Health Technology |
Kies MarketScreener 
